职位概述
高级会计负责协助总账核算及月度、季度和年度结账，并承担固定资产及预付款管理、资金管理、银行账户和外汇相关工作以及税务管理。该岗位要求候选人具备高度的细致性、扎实的会计核算基础、NetSuite 及网银/税务平台实操能力，并能够与内部需求人、供应商、银行、税务机关及审计师进行有效沟通和协调。
工作职责
- 总账相关会计处理，包括会计凭证编制及复核支持、科目余额核对、往来对账，以及预提、摊销、重分类等账务处理---工作量大概40%
- 月度、季度及年度结账，包括结账清单执行、账务核对、供应商对账、财务报表编制支持、审计资料准备及相关财务运营工作---工作量大概20%
- 负责固定资产及预付款管理，包括资产资本化判断、折旧、摊销、资产台账维护、预付款核算及跟踪，以及年度盘点支持---工作量大概10%
- 负责公司日常资金管理，包括付款安排、资金调拨、银行流水核对、现金对账及资金状况跟踪---工作量大概20%
- 负责处理银行账户维护、外汇/FDI/资本金、审计询证函及其他银行相关事项---工作量大概5%
- 负责税务申报及税务合规工作，包括增值税、印花税、企业所得税、代扣代缴增值税、发票管理及税务资料准备---工作量大概5%
任职资格：
- 会计、财务等相关专业本科及以上学历
- 至少6-7年相关工作经验，有出国留学或海外工作经验优先，有生物医药行业工作经验优先
- 中级会计师或以上职称，CPA是加分项
- 熟练使用Excel进行数据分析及财务报表处理，会使用Excel建模是加分项
- 熟悉ERP系统操作，具备NetSuite系统使用经验者优先
- 具备与内外部相关方高效沟通的能力，工作严谨细致，具备高度的合规意识
- 能够熟练使用英语进行书面及口头沟通，可独立参与跨国团队会议及跨部门协作
About Angitia:
Established in June 2018, Angitia Biopharmaceuticals is a multinational research and development enterprise focusing on discovery and development of new drugs for grievous bone, muscle and joint diseases. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development and management from both overseas and domestic large multinational companies. The company has built an organization distinguished by world-class scientists with talents that proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science includes internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking people who are competent, ambitious and great team players to join our vibrant group.
Our mission is to discover, develop and commercialize breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases.
Learn more at www.angitiabio.com.